PTI - Proteostasis Therapeutics - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

with an average price target of $-17.88. This is a potential upside of $-17.88 (0%) from yesterday's end of day stock price of $0.

Proteostasis Therapeutics's activity chart (see below) currently has 0 price targets and 5 ratings on display.

Stock Analyst Price Targets - Review

Most recent stock forecast was given by EDWARD TENTHOFF from PIPER SANDLER on 24-Aug-2020. First documented stock forecast 12-Aug-2016.

Best performing analysts who are covering PTI - Proteostasis Therapeutics:

Edward Tenthoff Brian Abrahams Joseph Schwartz

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

4

3 years 8 months 2 days ago

0/2 (0%)

$-15.43 (-77.39%)

Buy

8

$-14.1 (-63.80%)

4 years 8 months 18 days ago

0/1 (0%)

$-6.4 (-44.44%)

Buy

9

$-13.1 (-59.28%)

6 years 8 months 10 days ago

0/1 (0%)

$-31.8 (-77.94%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PTI (Proteostasis Therapeutics) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on PTI (Proteostasis Therapeutics) with a proven track record?

EDWARD TENTHOFF

Which analyst has the current lower performing score on PTI (Proteostasis Therapeutics) with a proven track record?

JOSEPH SCHWARTZ

Which analyst has the most public recommendations on PTI (Proteostasis Therapeutics)?

Edward Tenthoff works at PIPER SANDLER and has 7 price targets and 6 ratings on PTI

Which analyst is the currently most bullish on PTI (Proteostasis Therapeutics)?

Edward Tenthoff with highest potential upside - $0

Which analyst is the currently most reserved on PTI (Proteostasis Therapeutics)?

Brian Abrahams with lowest potential downside - -$14.1

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?